THE ESPERION STORY
Singularly Focused on Lipid Management for Everybody
In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target.1
We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades.
Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies.
Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several.
Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one.
Quelle: Esperion Therapeutics